MOSEIC
Live / Allowed — Publication / registration review complete (as of 16 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99500515
- Mark type
- Stylized text
- Filed
- 17 Nov 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Brent A. Johnson
Goods and services
- Class 001 — Chemicals: Bioavailability enhancing molecular complex as an intermediate product for use in the manufacture of pharmaceuticals for the treatment of migraines, neurological disorders and central nervous system disorders
Owner
- Axsome Therapeutics, Inc., New York, NY, US
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Jan 2026 — NON-FINAL ACTION E-MAILED
- 20 Jan 2026 — NON-FINAL ACTION WRITTEN
- 16 Jan 2026 — ASSIGNED TO EXAMINER
- 17 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Nov 2025 — NEW APPLICATION ENTERED